Skye Hodson, PhD, is an impact-driven leader with extensive experience in the life sciences sector, particularly in product strategy, clinical operations, and commercialization. Skye completed a PhD in Biochemistry and Biophysics at the University of Bristol, where they characterized a protein relevant to protein misfolding diseases. They have held several senior roles, including Executive Director at Syneos Health and VP at Norstella, where they focus on leveraging advanced analytics and digital solutions to enhance drug development outcomes. Skye is passionate about disrupting the status quo and mentoring others in innovative practices within the biopharma industry.
This person is not in any teams
This person is not in any offices